Mitochondrial disorders, a group of genetic diseases, have long lacked effective treatments. A new study led by Stanford Medicine suggests an unexpected approach: bone marrow transplants. The procedure appears to help diseased cells in the heart and brain obtain replacement parts, the researchers found.
The finding raises the possibility of the first effective therapy for these conditions. While the report does not detail the exact mechanism, it points to a surprising role for bone marrow in repairing cellular damage beyond the blood.
The research is at an early stage, and the source does not specify when clinical application might occur. Still, the results offer hope for patients with mitochondrial disease, who currently have limited options.